Giannettasio Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00526396
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Giannettasio Hospital, Department of Oncology and Hematology

Active Ingredients

Drugs in Phase 3 Trials (2)

cisplatin (platinol) (1 trial)

etoposide (vepesid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Neoplasms (Phase 3)

Small Cell Lung Carcinoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2